Figure 3
Associations of prophylactic use of nafamostat with the incidence of PIP in the six high-quality RCTs only. RR risk ratio, CI confidence interval, PIP post-endoscopic retrograde cholangiopancreatography pancreatitis.
Figure 3 | Scientific Reports
